Follicular Lymphoma

New cancer vaccine trial to begin at New York hospital

Published in Blood Weekly, December 11th, 2003

The first patient was recently vaccinated at New York University (NYU) Medical Center with a specific cancer vaccine designed to prevent tumor recurrences in patients who have already had a kind of cancer called follicular lymphoma.

Lymphoma is a cancer that begins in the lymph nodes. Malignant white blood cells multiply and grow into tumors, enlarging the lymph nodes and other sites in the body. There are many kinds of lymphoma, but one of the most common forms is follicular lymphoma, a low-grade or slow-growing form of the disease.

"Patients with follicular lymphoma are generally diagnosed in their 60s; however, in recent years we have seen an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-12-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry